Should a patient be denied access to a potentially life-saving drug like Remdesivir because a hospital was unable to comply with the sudden change in HHS reporting requirements?
Maxine Waters: “Should a patient be denied access to a potentially life-saving drug like Remdesivir because a hospital was unable to…”
Editor's note · Context
Waters questions the fairness of HHS reporting changes affecting drug access.
Share
More from Maxine Waters
Mr. Speaker, given the human rights violations committed by the Burmese leadership, we must ensure that no new funds are disbursed to the government. In line with longstanding U.S. policy, America should urge multilateral institutions like…
While no compromise is perfect, this legislation reflects meaningful progress and incorporates over 50 housing and banking provisions which Democrats fought to secure, but our work is far from done.
Mr. Speaker, there is a lot that Congress can do to help our community financial institutions. This includes taking up deposit insurance reform bills like the ones that I and my committee Republicans have put forward. Increasing deposit…





